Viewing Study NCT01758367

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:52 AM
Ignite Modification Date: 2026-02-21 @ 1:02 PM
Study NCT ID: NCT01758367
Status: UNKNOWN
Last Update Posted: 2016-08-31
First Post: 2012-12-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation
Sponsor: Chinese PLA General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Adult Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None demethylating agent View
None immunogenicity View
None decitabine(DAC) View
None donor lymphocyte infusion(DLI) View
None AML View